Laser Interstitial Thermal Therapy Induces Robust Local Immune Response for Newly Diagnosed Glioblastoma With Long-term Survival and Disease Control

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab

(2022) Helen Hwang et al.   CNS oncology

Laser ablation: Heating up the anti-tumor response in the intracranial compartment

(2022) Emily C. Lerner et al.   ADVANCED DRUG DELIVERY REVIEWS

The role of neutrophil-to-lymphocyte ratio in predicting overall survival in patients undergoing laser interstitial thermal therapy for glioblastoma

(2020) Javier M. Figueroa et al.   JOURNAL OF CLINICAL NEUROSCIENCE

In situ vaccination with laser interstitial thermal therapy augments immunotherapy in malignant gliomas

(2020) David H. Shin et al.   JOURNAL OF NEURO-ONCOLOGY

ATIM-45. LONG TERM FOLLOW-UP OF A PHASE I/II STUDY TESTING THE TOXICITIES AND EFFICACY OF PEMBROLIZUMAB IN COMBINATION WITH MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY (LITT) IN RECURRENT MALIGNANT GLIOMAS

(2019) Jian Campian et al.   NEURO-ONCOLOGY

Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity

(2017) Purnima Bhat et al.   Cell Death & Disease

Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier

(2016) Eric C. Leuthardt et al.   PLoS One

Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway

(2014) T. Chen et al.   JOURNAL OF IMMUNOLOGY